- Release Date: 22/12/14 14:09
- Summary: GENERAL: CVT: Edison Investment Research releases updated Comvita Report
- Price Sensitive: No
- Download Document 2.05KB
CVT 22/12/2014 14:09 GENERAL PRICE SENSITIVE REL: 1409 HRS Comvita Limited GENERAL: CVT: Edison Investment Research releases updated Comvita Report Edison Investment Research Limited has released an updated Comvita Report that is attached to this announcement. This Edison report has been written using publicly available information. Please note that the conclusions and opinions in the report are those of Edison Investment Research Limited. Edison Investment Research Limited will provide ongoing regular analysis which we will make available to shareholders. # Ends # For further information: Comvita CEO, Brett Hewlett, 021 740 160 Comvita Communications Manager, Julie Chadwick, 021 510 693 Background information About Comvita (www.comvita.com) Comvita (NZX:CVT) is a global natural health company committed to the development of innovative products, backed by ongoing investment in scientific research. We are the world leaders in Manuka (leptospermum) honey and fresh-picked Olive Leaf Extract, which are at the core of the Comvita product range. We have approximately 50% of honey supply under direct ownership or control, with the balance of supply from long term contractual and partnership arrangements. Comvita pioneered the development and use of medical grade Manuka honey and was the first to receive FDA approval (2007). We partner with US wound care company Derma Sciences, Inc. (NASDAQ:DSCI), the global licensee for Medihoney specialist wound care products, which are used in hospitals and medical centres around the world. Comvita's freshly picked Olive Leaf Extract is grown, harvested, extracted and bottled at the world's largest specialised olive leaf grove, with over one million olive trees. Comvita sells into more than 18 countries through a network of our own branded retail locations, online (nine country specific e-commerce websites) and third-party outlets. We have over 450 staff located in New Zealand, Australia, Hong Kong, Japan, Taiwan, South Korea, the United Kingdom and the USA. End CA:00259271 For:CVT Type:GENERAL Time:2014-12-22 14:09:06
- Forums
- NZX - By Stock
- Ann: GENERAL: CVT: Edison Investment Research releases updated Comvita Report
Ann: GENERAL: CVT: Edison Investment Research releases updated...
Featured News
Add CVT (NZSX) to my watchlist
(20min delay)
|
|||||
Last
$1.15 |
Change
-0.020(1.71%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
$1.17 | $1.18 | $1.15 | $35.17K | 30.38K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
0 | 33151 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 8952 | 0 |
Last trade - 11.00am 04/10/2024 (20 minute delay) ? |
Featured News
CVT (NZSX) Chart |